Mac Clinical Research
Cannock, United Kingdom
Research institute in England
Exchange House,, Watling St, Cannock WS11 0BN
About Mac Clinical Research
"MAC Clinical Research is a healthcare organisation dedicated to the development of new and improved treatments through clinical trials."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
4
Bristol-Myers Squibb
3
Anavex Life Sciences Corp.
2
AstraZeneca
2
Evelo Biosciences, Inc.
2
TauRx Therapeutics Ltd
2
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Pfizer
1
Tools4Patient
1
Clinical Trials at Mac Clinical Research
During the past decade, Mac Clinical Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
2013-01-01
2015-11-01
Completed
891
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
2014-08-01
2017-05-01
Terminated
913
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
2017-03-15
2018-10-02
Terminated
421
Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain
2017-09-18
2018-08-24
Completed
73
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2017-10-13
2024-03-01
Recruiting
550
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mac Clinical Research" #1 sponsor was "Allergan" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials
sponsored, "Anavex Life Sciences Corp." with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Evelo Biosciences, Inc."
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mac Clinical Research"
#1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Anavex Canada Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Mac Clinical Research
According to Clinical.Site data, the most researched conditions in "Mac Clinical Research" are
"Gastroparesis" (4 trials), "Psoriasis" (4 trials), "Alzheimer's Disease" (3 trials), "Diabetes Mellitus" (3 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Mac Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Mac Clinical Research
Most popular intervention types in "Mac Clinical Research" are "Drug" (18 trials), "Other" (4 trials), "Behavioral" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (3 trials), "Relamorelin" (3 trials), "Lanabecestat" (2 trials) and "Placebo oral capsule" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Mac Clinical Research
The vast majority of trials in "Mac Clinical Research" are
18 trials for "All" genders.
Clinical Trials Status at Mac Clinical Research
Currently, there are NaN active trials in "Mac Clinical Research".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Mac Clinical Research,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Mac Clinical Research, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".